Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
出版年份 2018 全文链接
标题
Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
作者
关键词
CTLA4, Dasatinib, MDSCs, Tregs, Immunotherapy, HNSCC
出版物
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-06-28
DOI
10.1007/s00018-018-2863-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma
- (2017) Jennifer D. Moy et al. EUROPEAN JOURNAL OF CANCER
- Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy
- (2017) Cristina Maccalli et al. IMMUNOLOGICAL INVESTIGATIONS
- NKG2D ligand RAE1ε induces generation and enhances the inhibitor function of myeloid-derived suppressor cells in mice
- (2017) Li Qian et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
- (2017) Stephen J. Bagley et al. LUNG CANCER
- Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients
- (2017) Luc Cabel et al. Journal for ImmunoTherapy of Cancer
- The promise of immunotherapy in head and neck squamous cell carcinoma
- (2016) P. Economopoulou et al. ANNALS OF ONCOLOGY
- Coinhibitory Pathways in Immunotherapy for Cancer
- (2016) Susanne H. Baumeister et al. Annual Review of Immunology
- Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer
- (2016) Liang Mao et al. INTERNATIONAL JOURNAL OF CANCER
- Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis
- (2016) Ami Patel et al. LIFE SCIENCES
- CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma
- (2016) Guang-Tao Yu et al. OncoImmunology
- CTLA-4+Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
- (2015) Hyun-Bae Jie et al. CANCER RESEARCH
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Immunology and Immunotherapy of Head and Neck Cancer
- (2015) Robert L. Ferris JOURNAL OF CLINICAL ONCOLOGY
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic pathways promoting cancer cell survival and growth
- (2015) Lindsey K. Boroughs et al. NATURE CELL BIOLOGY
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2014) D. T. Weed et al. CLINICAL CANCER RESEARCH
- Dasatinib promotes Th1-type responses in granzyme B expressing T-cells
- (2014) Anna Kreutzman et al. OncoImmunology
- Head and neck cancer: from anatomy to biology
- (2013) Pinaki Bose et al. INTERNATIONAL JOURNAL OF CANCER
- Chemopreventive and Chemotherapeutic Actions of mTOR Inhibitor in Genetically Defined Head and Neck Squamous Cell Carcinoma Mouse Model
- (2012) Z.-J. Sun et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Dasatinib in Patients with Metastatic Breast Cancer Using Real-Time Pharmacodynamic Tissue Biomarkers of Src Inhibition to Escalate Dosing
- (2011) Christina I. Herold et al. CLINICAL CANCER RESEARCH
- Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors
- (2011) J. C. Montero et al. CLINICAL CANCER RESEARCH
- Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation
- (2011) Y Bian et al. ONCOGENE
- Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
- (2010) F. Hochgrafe et al. CANCER RESEARCH
- Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors
- (2010) J. Baselga et al. CLINICAL CANCER RESEARCH
- Identification of c-Src as a Potential Therapeutic Target for Gastric Cancer and of MET Activation as a Cause of Resistance to c-Src Inhibition
- (2010) W. Okamoto et al. MOLECULAR CANCER THERAPEUTICS
- Targeted Inhibition of Src Kinase Signaling Attenuates Pancreatic Tumorigenesis
- (2010) Nagathihalli S. Nagaraj et al. MOLECULAR CANCER THERAPEUTICS
- A Kinase-Dead Allele of Lyn Attenuates Autoimmune Disease Normally Associated with Lyn Deficiency
- (2009) A. M. Verhagen et al. JOURNAL OF IMMUNOLOGY
- Src kinases as therapeutic targets for cancer
- (2009) Lori C. Kim et al. Nature Reviews Clinical Oncology
- The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation
- (2008) J. D. Wolchok et al. ONCOLOGIST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started